Back to search

Article

Efficacy and Safety of Fentanyl Inhalant for the Treatment of Breakthrough Cancer Pain: A Multicenter, Randomized, Double- blind, Placebo-controlled Trial

2024-03-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Breakthrough cancer pain (BTcP) has a negative impact on patients’ quality of life, general activities, and is related to worse clinical outcomes. Fentanyl inhalant is a hand-held combination drug-device delivery system providing rapid, multi-dose (25μg/dose) administration of fentanyl via inhalation of a thermally generated aerosol. This multicenter, randomized,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
089c4cd5-e85f-5bd7-9c5b-ba4d5288936d
DOI
10.21203/rs.3.rs-4104172/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Efficacy and Safety of Fentanyl Inhalant for the Treatment of Breakthrough Cancer Pain: A Multicenter, Randomized, Double- blind, Placebo-controlled TrialDOI 10.21203/rs.3.rs-4104172/v1
Select a neighboring publication to make it the new centre.